Search - tctmd.com

Displaying 421 - 440 of 722

Sort: Relevancy | Date

Presentation TCT 2015

Top 10 Lessons for Complication-Free TAVR

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Philippe Généreux

October 11, 2015

Presentation TCT 2015

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Oscar A. Mendiz

October 11, 2015

Presentation TCT 2015

Late Applications in TAVR

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Antonio Enrique Dager

October 11, 2015

Presentation TCT 2015

Is Cerebral Protection Necessary?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Alexandra J. Lansky

October 11, 2015

Presentation TCT 2015

How to Achieve 90% Success in Treating CTO Lesions

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Emmanouil S. Brilakis

October 11, 2015

Presentation TCT 2015

Routine IVUS and FFR: Is It Really Worth It?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Fernando Cura

October 11, 2015

Presentation TCT 2015

Three to Six Months of DAPT Is My Practice Even in Very Complex Cases: Heres Why

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Fausto Feres

October 11, 2015

Presentation TCT 2015

Who Receives Bioresorbable Scaffolds in My Practice, and What Are My Tips and Tricks?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Roberto Botelho

October 11, 2015

Presentation TCT 2015

Which Patients With Multivessel Disease and Diabetes Do I Treat With PCI, and How?

Presenter: Ricardo Lluberas, Roxana Mehran, Jamil Abdalla Saad, Expedito E. Ribeiro

October 11, 2015

Presentation TCT 2015

From WOEST, DAPT, and PEGASUS to GLOBAL LEADERS and TWILIGHT: What Answers Can We Expect (and Not Expect) From GLOBAL LEADERS and TWILIGHT?

Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Roxana Mehran

October 11, 2015

Presentation TCT 2015

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Presenter: Regina Deible, Roxana Mehran

October 11, 2015

News Industry News

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

October 08, 2015

News Daily News

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

L.A. McKeown

September 28, 2015

News Daily News

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

L.A. McKeown

September 28, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

News Daily News

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

September 22, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

News Daily News

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

L.A. McKeown

September 21, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

Advertisement

Top 10 Lessons for Complication-Free TAVR

How to Prevent Annular Rupture, Coronary Occlusion, and Permanent Pacemakers

Late Applications in TAVR

Is Cerebral Protection Necessary?

How to Achieve 90% Success in Treating CTO Lesions

Routine IVUS and FFR: Is It Really Worth It?

Three to Six Months of DAPT Is My Practice Even in Very Complex Cases: Heres Why

Who Receives Bioresorbable Scaffolds in My Practice, and What Are My Tips and Tricks?

Which Patients With Multivessel Disease and Diabetes Do I Treat With PCI, and How?

From WOEST, DAPT, and PEGASUS to GLOBAL LEADERS and TWILIGHT: What Answers Can We Expect (and Not Expect) From GLOBAL LEADERS and TWILIGHT?

Introduction: Why Is This Issue Important? Ischemia vs Bleeding

Abiomed's Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content